Wang D, Jiang Q, Dong Z, Meng T, Hu F, Wang J, Yuan H. Nanocarriers transport across the gastrointestinal barriers: the contribution to oral bioavailability via blood circulation and lymphatic pathway. Adv Drug Deliv Rev. 2023;203:115130.
Miller MK, Chapa-Villarreal FA, Oldenkamp HF, Elder MG, Venkataraman AK, Peppas NA. Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies. J Control Release. 2023;361:246–59.
Xu M, Qi Y, Liu G, Song Y, Jiang X, Du B. Size-dependent in vivo transport of nanoparticles: implications for delivery, targeting, and Clearance. ACS Nano. 2023;17(21):20825–49.
Zhuo Y, Luo Z, Zhu Z, Wang J, Li X, Zhang Z, Guo C, Wang B, Nie D, Gan Y, Hu G, Yu M. Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes. Nat Nanotechnol 2024. https://doi.org/10.1038/s41565-024-01785-0
Hunt NJ, Lockwood GP, Heffernan SJ, Daymond J, Ngu M, Narayanan RK, Westwood LJ, Mohanty B, Esser L, Williams CC, Kuncic Z, McCourt PAG, Le Couteur DG, Cogger VC. Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia. Nat Nanotechnol. 2024;19(4):534–44.
Liu L, Yao W, Rao Y, Lu X, Gao J. pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms. Drug Deliv. 2017;24(1):569–81.
Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: design, evaluation and state-of-the-art. J Control Release. 2016;240:504–26.
Pelaseyed T, Hansson GC. Membrane mucins of the intestine at a glance. J Cell Sci. 2020;133(5):jcs240929.
Benoit DSW, Sims KR Jr, Fraser D. Nanoparticles for oral biofilm treatments. ACS Nano. 2019;13(5):4869–75.
Makvandi P, Josic U, Delfi M, Pinelli F, Jahed V, Kaya E, Ashrafizadeh M, Zarepour A, Rossi F, Zarrabi A, Agarwal T, Zare EN, Ghomi M, Kumar Maiti T, Breschi L, Tay FR. Drug delivery (Nano)platforms for oral and Dental Applications: tissue regeneration, infection control, and Cancer Management. Adv Sci (Weinh). 2021;8(8):2004014.
Wang T, Luo Y. Biological fate of ingested lipid-based nanoparticles: current understanding and future directions. Nanoscale. 2019;11(23):11048–63.
He Y, Cheng M, Yang R, Li H, Lu Z, Jin Y, Feng J, Tu L. Research Progress on the mechanism of nanoparticles crossing the intestinal epithelial cell membrane. Pharmaceutics. 2023;15(7):1816.
Griffiths G, Gruenberg J, Marsh M, Wohlmann J, Jones AT, Parton RG. Nanoparticle entry into cells; the cell biology weak link. Adv Drug Deliv Rev. 2022;188:114403.
Madni A, Rehman S, Sultan H, Khan MM, Ahmad F, Raza MR, Rai N, Parveen F. Mechanistic approaches of internalization, subcellular trafficking, and cytotoxicity of nanoparticles for targeting the small intestine. AAPS PharmSciTech. 2020;22(1):3.
Zhen W, An S, Wang S, Hu W, Li Y, Jiang X, Li J. Precise subcellular organelle targeting for boosting endogenous-stimuli-mediated Tumor Therapy. Adv Mater. 2021;33(51):e2101572.
Li Q, Xia D, Tao J, Shen A, He Y, Gan Y, et al. Self-assembled core-shell-type lipid-polymer hybrid nanoparticles: intracellular trafficking and relevance for oral absorption. J Pharm Sci. 2017;106(10):3120–30.
Ehrlich M, Boll W, Van Oijen A, Hariharan R, Chandran K, Nibert ML, Kirchhausen T. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell. 2004;118(5):591–605.
Wang Z, Tiruppathi C, Cho J, Minshall RD, Malik AB. Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life. 2011;63(8):659–67.
Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16(3):266–76.
Means N, Elechalawar CK, Chen WR, Bhattacharya R, Mukherjee P. Revealing macropinocytosis using nanoparticles. Mol Aspects Med. 2022;83:100993.
Donahue ND, Acar H, Wilhelm S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv Drug Deliv Rev. 2019;143:68–96.
Spleis H, Sandmeier M, Claus V, Bernkop-Schnürch A. Surface design of nanocarriers: key to more efficient oral drug delivery systems. Adv Colloid Interface Sci. 2023;313:102848.
Ejazi SA, Louisthelmy R, Maisel K. Mechanisms of Nanoparticle Transport across intestinal tissue: an oral delivery perspective. ACS Nano. 2023;17(14):13044–61.
Li Y, Zhang M, Zhang Y, Niu X, Liu Z, Yue T, Zhang W. A computational study of the influence of nanoparticle shape on clathrin-mediated endocytosis. J Mater Chem B. 2023;11(27):6319–34.
Gurnani P, Sanchez-Cano C, Xandri-Monje H, Zhang J, Ellacott SH, Mansfield EDH, Hartlieb M, Dallmann R, Perrier S. Probing the Effect of Rigidity on the Cellular Uptake of Core-Shell nanoparticles: Stiffness effects are size dependent. Small. 2022;18(38):e2203070.
Guo S, Liang Y, Liu L, Yin M, Wang A, Sun K, Li Y, Shi Y. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. J Nanobiotechnol. 2021;19(1):32.
Popov LD. Deciphering the relationship between caveolae-mediated intracellular transport and signalling events. Cell Signal. 2022;97:110399.
El-Sayed A, Harashima H. Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol Ther. 2013;21(6):1118–30.
Wang Y, Ke J, Guo X, Gou K, Sang Z, Wang Y, Bian Y, Li S, Li H. Chiral mesoporous silica nano-screws as an efficient biomimetic oral drug delivery platform through multiple topological mechanisms. Acta Pharm Sin B. 2022;12(3):1432–46.
Dou T, Wang J, Han C, Shao X, Zhang J, Lu W. Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers. Int J Biol Macromol. 2019;138:791–9.
Miao YB, Chen KH, Chen CT, Mi FL, Lin YJ, Chang Y, Chiang CS, Wang JT, Lin KJ, Sung HW. A noninvasive gut-to-brain oral drug delivery system for treating brain tumors. Adv Mater. 2021;33(34):e2100701.
Rueda-Gensini L, Cifuentes J, Castellanos MC, Puentes PR, Serna JA, Muñoz-Camargo C, Cruz JC. Tailoring Iron Oxide nanoparticles for efficient Cellular internalization and endosomal escape. Nanomaterials (Basel). 2020;10(9):1816.
Deng F, Zhang H, Wang X, Zhang Y, Hu H, Song S, Dai W, He B, Zheng Y, Wang X, Zhang Q. Transmembrane pathways and mechanisms of rod-like Paclitaxel nanocrystals through MDCK polarized monolayer. ACS Appl Mater Interfaces. 2017;9(7):5803–16.
Zou Y, Gao W, Jin H, Mao C, Zhang Y, Wang X, Mei D, Zhao L. Cellular Uptake and Transport mechanism of 6-Mercaptopurine nanomedicines for enhanced oral bioavailability. Int J Nanomed. 2023;18:79–94.
Mellman I, Nelson WJ. Coordinated protein sorting, targeting and distribution in polarized cells. Nat Rev Mol Cell Bio. 2008;9(11):833–45.
Andrian T, Riera R, Pujals S, Albertazzi L. Nanoscopy for endosomal escape quantification. Nanoscale Adv. 2020;3(1):10–23.
Qiu C, Xia F, Zhang J, Shi Q, Meng Y, Wang C, Pang H, Gu L, Xu C, Guo Q, Wang J. Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery. Res (Wash D C). 2023;6:0148.
Li X, Jafari SM, Zhou F, Hong H, Jia X, Mei X, Hou G, Yuan Y, Liu B, Chen S, Gong Y, Yan H, Chang R, Zhang J, Ren F, Li Y. The intracellular fate and transport mechanism of shape, size and rigidity varied nanocarriers for understanding their oral delivery efficiency. Biomaterials. 2023;294:121995.
Zhang R, Deng H, Lin Y, Wang X, He B, Dai W, Zhang H, Zheng Y, Zhang Q, Wang X. A common strategy to improve transmembrane transport in polarized epithelial cells based on sorting signals: guiding nanocarriers to TGN rather than to the basolateral plasma membrane directly. J Control Release. 2021;339:430–44.
Joris F, De Backer L, Van de Vyver T, Bastiancich C, De Smedt SC, Raemdonck K. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells. J Control Release. 2018;269:266–76.
Xu Y, Zheng Y, Wu L, Zhu X, Zhang Z, Huang Y. Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin. ACS Appl Mater Interfaces. 2018;10(11):9315–24.
Malik S, Saltzman WM, Bahal R. Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids. Mol Ther Nucleic Acids. 2021;25:302–15.
Sipos A, Kim KJ, Chow RH, Flodby P, Borok Z, Crandall ED. Alveolar epithelial cell processing of nanoparticles activates autophagy and lysosomal exocytosis. Am J Physiol Lung Cell Mol Physiol. 2018;315(2):L286–300.
Yang D, Feng Y, Yuan Y, Zhang L, Zhou Y, Midgley AC, Wang Y, Liu N, Li G, Yao X, Liu D. Protein coronas derived from mucus act as both Spear and Shield to Regulate Transferrin Functionalized Nanoparticle Transcellular Transport in Enterocytes. ACS Nano. 2024;18(10):7455–72.
Chen LQ, Liu CD, Xiang YC, Lyu JY, Zhou Z, Gong T, Gao HL, Li L, Huang Y. Exocytosis blockade of endoplasmic reticulum-targeted nanoparticle enhances immunotherapy. Nano Today. 2022;42:101356.
Xing L, Zheng Y, Yu Y, Wu R, Liu X, Zhou R, Huang Y. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs. J Mater Chem B. 2021;9(6):1707–18.
He B, Lin P, Jia Z, Du W, Qu W, Yuan L, Dai W, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells. Biomaterials. 2013;34(25):6082–98.
Yin Y, Yang J, Pan Y, Guo Z, Gao Y, Huang L, Zhou D, Ge Y, Guo F, Zhu W, Song Y, Li Y. Chylomicrons-simulating sustained drug release in Mesenteric Lymphatics for the treatment of Crohn’s-Like Colitis. J Crohns Colitis. 2021;15(4):631–46.
Yoshida T, Kojima H, Sako K, Kondo H. Drug delivery to the intestinal lymph by oral formulations. Pharm Dev Technol. 2022;27(2):175–89.
Deng F, Kim KS, Moon J, Bae YH. Bile acid conjugation on solid nanoparticles enhances ASBT-Mediated endocytosis and chylomicron pathway but weakens the transcytosis by Inducing Transport Flow in a Cellular negative feedback Loop. Adv Sci (Weinh). 2022;9(21):e2201414.
Yang D, Liu D, Qin M, Chen B, Song S, Dai W, Zhang H, Wang X, Wang Y, He B, Tang X, Zhang Q. Intestinal mucin induces more endocytosis but less transcytosis of nanoparticles across enterocytes by triggering Nanoclustering and strengthening the Retrograde Pathway. ACS Appl Mater Interfaces. 2018;10(14):11443–56.
Wu L, Bai Y, Liu M, Li L, Shan W, Zhang Z, Huang Y. Transport mechanisms of Butyrate Modified nanoparticles: insight into Easy Entry, hard transcytosis of active targeting system in oral administration. Mol Pharm. 2018;15(9):4273–83.
Asad S, Jacobsen A-C, Teleki A. Inorganic nanoparticles for oral drug delivery: opportunities, barriers, and future perspectives. Curr Opin Chem Eng. 2022;38:100869.
García-Díaz M, Birch D, Wan F, Nielsen HM. The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles. Adv Drug Deliv Rev. 2018;124:107–24.
McCright J, Sinha A, Maisel K. Generating an in vitro gut model with physiologically relevant Biophysical mucus Properties. Cell Mol Bioeng. 2022;15(5):479–91.
Araújo F, Martins C, Azevedo C, Sarmento B. Chemical modification of drug molecules as strategy to reduce interactions with mucus. Adv Drug Deliv Rev. 2018;124:98–106.
Xie Y, Jin Z, Ma D, Yin TH, Zhao K. Palmitic acid- and cysteine-functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug. Bioeng Transl Med. 2023;8(3):e10510.
Guaresti O, Maiz–Fernández S, Palomares T, Alonso–Varona A, Eceiza A, Pérez–Álvarez L, Gabilondo N. Dual charged folate labelled Chitosan nanogels with enhanced mucoadhesion capacity for targeted drug delivery. Eur Polym J. 2020;134:109847.
Zhou S, Deng H, Zhang Y, Wu P, He B, Dai W, Zhang H, Zhang Q, Zhao R, Wang X. Thiolated nanoparticles overcome the mucus barrier and epithelial barrier for oral delivery of insulin. Mol Pharm. 2020;17(1):239–50.
Cui Z, Cui S, Qin L, An Y, Zhang X, Guan J, Wong TW, Mao S. Comparison of virus-capsid mimicking biologic-shell based versus polymeric-shell nanoparticles for enhanced oral insulin delivery. Asian J Pharm Sci. 2023;18(5):100848.
Le Z, He Z, Liu H, Liu L, Liu Z, Chen Y. Antioxidant enzymes sequestered within lipid-polymer hybrid nanoparticles for the local treatment of inflammatory bowel disease. ACS Appl Mater Interfaces. 2021;13(47):55966–77.
Gao Y, He Y, Zhang H, Zhang Y, Gao T, Wang JH, Wang S. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers. J Colloid Interface Sci. 2021;582(Pt A):364–75.
Efiana NA, Phan TNQ, Wicaksono AJ, Bernkop-Schnürch A. Mucus permeating self-emulsifying drug delivery systems (SEDDS): about the impact of mucolytic enzymes. Colloids Surf B Biointerfaces. 2018;161:228–35.
Razzaq S, Rauf A, Raza A, Akhtar S, Tabish TA, Sandhu MA, Zaman M, Ibrahim IM, Shahnaz G, Rahdar A, Díez-Pascual AM. A multifunctional polymeric micelle for targeted delivery of Paclitaxel by the inhibition of the P-Glycoprotein transporters. Nanomaterials (Basel). 2021;11(11):2858.
Shen Y, Qiu L. Effective oral delivery of gp100 plasmid vaccine against metastatic melanoma through multi-faceted blending-by-blending nanogels. Nanomedicine. 2019;22:102114.
Pereira de Sousa I, Cattoz B, Wilcox MD, Griffiths PC, Dalgliesh R, Rogers S, Bernkop-Schnürch A. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier. Eur J Pharm Biopharm. 2015;97(Pt A):257–64.
Desai DD, Manikkath J, Lad H, Kulkarni M, Manikkath A, Radhakrishnan R. Nanotechnology-based mucoadhesive and mucus-penetrating drug-delivery systems for transbuccal drug delivery. Nanomed (Lond). 2023;18(21):1495–514.
Wang Y, Shen J, Handschuh-Wang S, Qiu M, Du S, Wang B. Microrobots for targeted delivery and therapy in Digestive System. ACS Nano. 2023;17(1):27–50.
Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnol. 2022;20(1):362.
Amin MK, Boateng JS. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface modification with Sodium Alginate and Polyethylene Glycol for potential oral mucosa vaccine delivery. Mar Drugs. 2022;20(3):156.
Cao P, Wang J, Sun B, Rewatkar P, Popat A, Fu C, Peng H, Xu ZP, Li L. Enhanced mucosal transport of polysaccharide-calcium phosphate nanocomposites for oral vaccination. ACS Appl Bio Mater. 2021;4(11):7865–78.
Serra-Casablancas M, Di Carlo V, Esporrín-Ubieto D, Prado-Morales C, Bakenecker AC, Sánchez S. Catalase-powered nanobots for overcoming the mucus barrier. ACS Nano. 2024;18:16701–14.
Tian Z, Mai Y, Meng T, Ma S, Gou G, Yang J. Nanocrystals for improving oral bioavailability of drugs: intestinal transport mechanisms and influencing factors. AAPS PharmSciTech. 2021;22(5):179.
Yu SH, Tang DW, Hsieh HY, Wu WS, Lin BX, Chuang EY, Sung HW, Mi FL. Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers. Acta Biomater. 2013;9(7):7449–59.
Wu J, Zhu Z, Liu W, Zhang Y, Kang Y, Liu J, Hu C, Wang R, Zhang M, Chen L, Shao L. How nanoparticles open the Paracellular Route of Biological barriers: mechanisms, applications, and prospects. ACS Nano. 2022;16(10):15627–52.
Sabu C, Raghav D, Jijith US, Mufeedha P, Naseef PP, Rathinasamy K, Pramod K. Bioinspired oral insulin delivery system using yeast microcapsules. Mater Sci Eng C Mater Biol Appl. 2019;103:109753.
Surwase SS, Shahriar SMS, An JM, Ha J, Mirzaaghasi A, Bagheri B, Park JH, Lee YK, Kim YC. Engineered nanoparticles inside a microparticle oral system for enhanced mucosal and systemic immunity. ACS Appl Mater Interfaces. 2022;14(9):11124–43.
Song JG, Lee SH, Han HK. Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterization. J Nanobiotechnol. 2021;19(1):15.
He Y, Huang Y, Xu H, Yang X, Liu N, Xu Y, Ma R, Zhai J, Ma Y, Guan S. Aptamer-modified M cell targeting liposomes for oral delivery of macromolecules. Colloids Surf B Biointerfaces. 2023;222:113109.
Liu RG, Fei SY, Zhang XM, Zheng H, Tan MQ. Layer-by-layer oral-deliverable nanoparticles targeted microfold cells to promote lutein absorption in alleviating dry eye disease. Chem Eng J. 2024;479:147590.
Ma Y, He H, Xia F, Li Y, Lu Y, Chen D, Qi J, Lu Y, Zhang W, Wu W. In vivo fate of lipid-silybin conjugate nanoparticles: implications on enhanced oral bioavailability. Nanomedicine. 2017;13(8):2643–54.
Kanaya T, Williams IR, Ohno H. Intestinal M cells: tireless samplers of enteric microbiota. Traffic. 2020;21(1):34–44.
Kim KS, Na K, Bae YH. Nanoparticle oral absorption and its clinical translational potential. J Control Release. 2023;360:149–62.
Durán-Lobato M, Niu Z, Alonso MJ. Oral delivery of Biologics for Precision Medicine. Adv Mater. 2020;32(13):e1901935.
Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol. 2001;2(11):1004–9.
Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK. Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm. 2013;447(1–2):75–93.
Faria AM, Weiner HL. Oral tolerance. Immunol Rev. 2005;206:232–59.
Long P, Zhang Q, Xue M, Cao G, Li C, Chen W, et al. Tomato lectin-modified nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine: targeting intestinal M cells following peroral administration. Biomed Pharmacother. 2019;115:108886.
France MM, Turner JR. The mucosal barrier at a glance. J Cell Sci. 2017;130(2):307–14.
Ma L, Ma Y, Gao Q, Liu S, Zhu Z, Shi X, Dai F, Reis RL, Kundu SC, Cai K, Xiao B. Mulberry Leaf lipid nanoparticles: a naturally targeted CRISPR/Cas9 oral delivery platform for alleviation of Colon diseases. Small. 2024;20(25):e2307247.
Schoultz I, Keita ÅV. Cellular and molecular therapeutic targets in inflammatory bowel disease-focusing on intestinal barrier function. Cells. 2019;8(2):193.
Xu J, Xu J, Shi T, Zhang Y, Chen F, Yang C, Guo X, Liu G, Shao D, Leong KW, Nie G. Probiotic-inspired nanomedicine restores intestinal homeostasis in colitis by regulating Redox Balance, Immune responses, and the gut Microbiome. Adv Mater. 2023;35(3):e2207890.
Zhang Y, Wu Y, Yan Y, Ma Y, Tu L, Shao J, Tang X, Chen L, Liang G, Yin L. Dual-targeted nanoparticle-in-Microparticle System for Ulcerative Colitis Therapy. Adv Healthc Mater. 2023;12(31):e2301518.
Zu M, Ma Y, Zhang J, Sun J, Shahbazi MA, Pan G, Reis RL, Kundu SC, Liu J, Xiao B. An oral nanomedicine elicits in situ Vaccination Effect against Colorectal Cancer. ACS Nano. 2024;18(4):3651–68.
Huang Y, Huang X, Wang Z, He F, Huang Z, Chen C, Tang B, Qin M, Wu Y, Long C, Tang W, Mo X, Liu J. Analysis of differences in intestinal flora associated with different BMI status in colorectal cancer patients. J Transl Med. 2024;22(1):142.
Fu YJ, Zhao X, Wang LY, Li K, Jiang N, Zhang ST, Wang RK, Zhao YF, Yang W. A gas therapy strategy for intestinal Flora Regulation and Colitis Treatment by Nanogel-based multistage NO delivery microcapsules. Adv Mater. 2024;36(19):e2309972.
Lee SY, Jhun J, Woo JS, Lee KH, Hwang SH, Moon J, Park G, Choi SS, Kim SJ, Jung YJ, Song KY, Cho ML. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. Gut Microbes. 2024;16(1):2300846.
Yong SB, Park OH, Cho SC. Microbiome-derived lipid nanoparticles for Improved Immunogenicity of mRNA vaccines. ACS Mater Lett. 2024;6(4):1557–63.
Huang Y, Xu J, Sun G, Cheng X, An Y, Yao X, et al. Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome. Biomaterials. 2024;314:122822.
Marasini N, Giddam AK, Ghaffar KA, Batzloff MR, Good MF, Skwarczynski M, Toth I. Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group a Streptococcus. Nanomed (Lond). 2016;11(10):1223–36.
Li M, Kaminskas LM, Marasini N. Recent advances in nano/microparticle-based oral vaccines. J Pharm Investig. 2021;51(4):425–38.
Ren Q, Ma J, Li X, Meng Q, Wu S, Xie Y, Qi Y, Liu S, Chen R. Intestinal toxicity of metal nanoparticles: silver nanoparticles disorder the intestinal Immune Microenvironment. ACS Appl Mater Interfaces. 2023;15(23):27774–88.
Mao X, Nguyen TH, Lin M, Mustapha A. Engineered nanoparticles as potential food contaminants and their toxicity to Caco-2 cells. J Food Sci. 2016;81(8):T2107–13.
Pogribna M, Word B, Lyn-Cook B, Hammons G. Effect of titanium dioxide nanoparticles on histone modifications and histone modifying enzymes expression in human cell lines. Nanotoxicology. 2022;16(4):409–24.
Li J, Mao H, Kawazoe N, Chen G. Insight into the interactions between nanoparticles and cells. Biomater Sci-uk. 2017;5(2):173–89.
Obinu A, Porcu EP, Piras S, Ibba R, Carta A, Molicotti P, Migheli R, Dalpiaz A, Ferraro L, Rassu G, Gavini E, Giunchedi P. Solid lipid nanoparticles as Formulative Strategy to increase oral permeation of a molecule active in Multidrug-Resistant Tuberculosis Management. Pharmaceutics. 2020;12(12):1132.
Guo Z, Cao X, DeLoid GM, Sampathkumar K, Ng KW, Loo SCJ, Demokritou P. Physicochemical and morphological transformations of Chitosan nanoparticles across the gastrointestinal Tract and Cellular Toxicity in an in vitro model of the small intestinal epithelium. J Agric Food Chem. 2020;68(1):358–68.
Tian Y, Hu Q, Sun Z, Yu Y, Li X, Tian T, et al. Colon targeting pH-responsive coacervate microdroplets for treatment of ulcerative colitis. Small. 2024;20(33):2311890.
Yang W, Ma Y, Xu H, Zhu Z, Wu J, Xu C, et al. Mulberry biomass-derived nanomedicines mitigate colitis through improved inflamed mucosa accumulation and intestinal microenvironment modulation. Research. 2023;6:188.
Xu Y, Carradori D, Alhouayek M, Muccioli GG, Cani PD, Préat V, Beloqui A. Size effect on lipid nanocapsule-mediated GLP-1 secretion from Enteroendocrine L cells. Mol Pharm. 2018;15(1):108–15.
Ma Y, Gou S, Zhu Z, Sun J, Shahbazi MA, Si T, Xu C, Ru J, Shi X, Reis RL, Kundu SC, Ke B, Nie G, Xiao B. Transient mild photothermia improves therapeutic performance of oral nanomedicines with enhanced Accumulation in the Colitis Mucosa. Adv Mater. 2024;36(14):e2309516.
Wei X, Yu S, Zhang T, Liu L, Wang X, Wang X, Chan YS, Wang Y, Meng S, Chen YG. MicroRNA-200 loaded lipid nanoparticles promote intestinal epithelium regeneration in Canonical MicroRNA-Deficient mice. ACS Nano. 2023;17(22):22901–15.
Zhang C, Wang H, Yang X, Fu Z, Ji X, Shi Y, Zhong J, Hu W, Ye Y, Wang Z, Ni D. Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy. Sci Adv. 2022;8(37):eabp9882.
Li B, Zu M, Jiang A, Cao Y, Wu J, Shahbazi MA, Shi X, Reis RL, Kundu SC, Xiao B. Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation. Biomaterials. 2024;307:122530.
Li Y, Zhang M, Niu X, Yue T. Selective membrane wrapping on differently sized nanoparticles regulated by clathrin assembly: a computational model. Colloids Surf B Biointerfaces. 2022;214:112467.
Wei Y, Chen H, Li YX, He K, Yang K, Pang HB. Synergistic entry of individual nanoparticles into mammalian cells driven by Free Energy decline and regulated by their sizes. ACS Nano. 2022;16(4):5885–97.
Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N, Shen G. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduct Target Ther. 2024;9(1):34.
Zaiter T, Cornu R, Millot N, Herbst M, Pellequer Y, Moarbess G, Martin H, Diab-Assaf M, Béduneau A. Size effect and mucus role on the intestinal toxicity of the E551 food additive and engineered silica nanoparticles. Nanotoxicology. 2022;16(2):165–82.
Liang Y, Ding R, Wang H, Liu L, He J, Tao Y, Zhao Z, Zhang J, Wang A, Sun K, Li Y, Shi Y. Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption. Drug Deliv. 2022;29(1):305–15.
Wu M, Guo H, Liu L, Liu Y, Xie L. Size-dependent cellular uptake and localization profiles of silver nanoparticles. Int J Nanomed. 2019;14:4247–59.
Billah MM, Deng H, Dutta P, Liu J. Effects of receptor properties on particle internalization through receptor-mediated endocytosis. Soft Matter. 2023;19(31):5907–15.
Shen Z, Ye H, Yi X, Li Y. Membrane wrapping efficiency of Elastic nanoparticles during endocytosis: size and shape matter. ACS Nano. 2019;13(1):215–28.
Gao H, Shi W, Freund LB. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 2005;102(27):9469–74.
Ding HM, Ma YQ. Theoretical and computational investigations of nanoparticle-biomembrane interactions in cellular delivery. Small. 2015;11(9–10):1055–71.
Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1–16.
Ogawa T, Okumura R, Nagano K, Minemura T, Izumi M, Motooka D, Nakamura S, Iida T, Maeda Y, Kumanogoh A, Tsutsumi Y, Takeda K. Oral intake of silica nanoparticles exacerbates intestinal inflammation. Biochem Biophys Res Commun. 2021;534:540–6.
Wang Y, Pi C, Feng X, Hou Y, Zhao L, Wei Y. The influence of Nanoparticle properties on oral bioavailability of drugs. Int J Nanomed. 2020;15:6295–310.
Gardey E, Cseresnyes Z, Sobotta FH, Eberhardt J, Haziri D, Grunert PC, Kuchenbrod MT, Gruschwitz FV, Hoeppener S, Schumann M, Gaßler N, Figge MT, Stallmach A, Brendel JC. Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles. Small. 2024;20(21):e2306482.
Yang T, Wang A, Nie D, Fan W, Jiang X, Yu M, Guo S, Zhu C, Wei G, Gan Y. Ligand-switchable nanoparticles resembling viral surface for sequential drug delivery and improved oral insulin therapy. Nat Commun. 2022;13(1):6649.
Zhang D, He J, Cui J, Wang R, Tang Z, Yu H, Zhou M. Oral Microalgae-Nano Integrated System against Radiation-Induced Injury. ACS Nano. 2023;17(11):10560–76.
Zhong D, Zhang D, Chen W, He J, Ren C, Zhang X, Kong N, Tao W, Zhou M. Orally deliverable strategy based on microalgal biomass for intestinal disease treatment. Sci Adv. 2021;7(48):eabi9265.
Iriarte-Mesa C, Jobst M, Bergen J, Kiss E, Ryoo R, Kim JC, Crudo F, Marko D, Kleitz F, Del Favero G. Morphology-Dependent Interaction of silica nanoparticles with intestinal cells: connecting shape to barrier function. Nano Lett. 2023;23(16):7758–66.
Bao C, Liu B, Li B, Chai J, Zhang L, Jiao L, Li D, Yu Z, Ren F, Shi X, Li Y. Enhanced transport of shape and rigidity-tuned α-Lactalbumin nanotubes across intestinal mucus and Cellular barriers. Nano Lett. 2020;20(2):1352–61.
Zhou W, Li B, Min R, Zhang Z, Huang G, Chen Y, Shen B, Zheng Q, Yue P. Mucus-penetrating dendritic mesoporous silica nanoparticle loading drug nanocrystal clusters to enhance permeation and intestinal absorption. Biomater Sci. 2023;11(3):1013–30.
Christfort JF, Guillot AJ, Melero A, Thamdrup LHE, Garrigues TM, Boisen A, Zór K, Nielsen LH. Cubic microcontainers improve in situ colonic mucoadhesion and absorption of Amoxicillin in rats. Pharmaceutics. 2020;12(4):355.
Sang Z, Xu L, Ding R, Wang M, Yang X, Li X, Zhou B, Gou K, Han Y, Liu T, Chen X, Cheng Y, Yang H, Li H. Nanoparticles exhibiting virus-mimic surface topology for enhanced oral delivery. Nat Commun. 2023;14(1):7694.
Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release. 2016;238:176–85.
Li D, Zhuang J, He H, Jiang S, Banerjee A, Lu Y, Wu W, Mitragotri S, Gan L, Qi J. Influence of particle geometry on gastrointestinal transit and absorption following oral administration. ACS Appl Mater Interfaces. 2017;9(49):42492–502.
Yang L, Guo J, Wang L, Tang S, Wang AF, Zheng S, Guo Z, Zan X. Transformation of the shape and shrinking the size of acid-resistant metal-organic frameworks (MOFs) for use as the vehicle of oral proteins. Biomater Sci. 2023;11(10):3726–36.
Cao Y, Janjua TI, Qu Z, Draphoen B, Bai Y, Linden M, Moniruzzaman M, Hasnain SZ, Kumeria T, Popat A. Virus-like silica nanoparticles enhance macromolecule permeation in vivo. Biomater Sci. 2023;11(13):4508–21.
Liu N, Becton M, Zhang L, Wang X. Mechanism of coupling nanoparticle stiffness with shape for endocytosis: from Rodlike Penetration to Wormlike Wriggling. J Phys Chem B. 2020;124(49):11145–56.
Zhang Y, Tekobo S, Tu Y, Zhou Q, Jin X, Dergunov SA, Pinkhassik E, Yan B. Permission to enter cell by shape: nanodisk vs nanosphere. ACS Appl Mater Interfaces. 2012;4(8):4099–105.
García-Rodríguez A, Vila L, Cortés C, Hernández A, Marcos R. Effects of differently shaped TiO2NPs (nanospheres, nanorods and nanowires) on the in vitro model (Caco-2/HT29) of the intestinal barrier. Part Fibre Toxicol. 2018;15(1):33.
Zhang C, Zhang H, Millán Cotto HA, Boyer TL, Warren MR, Wang CM, Luchan J, Dhal PK, Carrier RL, Bajpayee AG. Milk exosomes anchored with hydrophilic and zwitterionic motifs enhance mucus permeability for applications in oral gene delivery. Biomater Sci. 2024;12(3):634–49.
Li Y, Chen X, Gu N. Computational investigation of interaction between nanoparticles and membranes: hydrophobic/hydrophilic effect. J Phys Chem B. 2008;112(51):16647–53.
Sanjula B, Shah FM, Javed A, Alka A. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target. 2009;17(3):249–56.
Griffin BT, Guo J, Presas E, Donovan MD, Alonso MJ, O’Driscoll CM. Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs. Adv Drug Deliv Rev. 2016;106(Pt B):367–80.
Wang T, Shen L, Zhang Y, Li H, Wang Y, Quan D. Oil-soluble reversed lipid nanoparticles for oral insulin delivery. J Nanobiotechnol. 2020;18(1):98.
Li J, Qiang H, Yang W, Xu Y, Feng T, Cai H, Wang S, Liu Z, Zhang Z, Zhang J. Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles. J Control Release. 2022;341:31–43.
Attar ES, Jayakumar S, Devarajan PV. Oral In-Situ nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport across Gastrointestinal Mucosa. AAPS PharmSciTech. 2024;25(5):113.
Xu J, Wen L, Zhang F, Lin W, Zhang L. Self-assembly of cyclic grafted copolymers with rigid rings and their potential as drug nanocarriers. J Colloid Interface Sci. 2021;597:114–25.
Zheng Y, Xing L, Chen L, Zhou R, Wu J, Zhu X, Li L, Xiang Y, Wu R, Zhang L, Huang Y. Tailored elasticity combined with biomimetic surface promotes nanoparticle transcytosis to overcome mucosal epithelial barrier. Biomaterials. 2020;262:120323.
Kevadiya BD, Ottemann BM, Thomas MB, Mukadam I, Nigam S, McMillan J, Gorantla S, Bronich TK, Edagwa B, Gendelman HE. Neurotheranostics as personalized medicines. Adv Drug Deliv Rev. 2019;148:252–89.
Efiana NA, Fürst A, Saleh A, Shahzadi I, Bernkop-Schnürch A. Phosphate decorated lipid-based nanocarriers providing a prolonged mucosal residence time. Int J Pharm. 2022;625:122096.
Martínez-López AL, González-Navarro CJ, Aranaz P, Vizmanos JL, Irache JM. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions. Acta Pharm Sin B. 2021;11(4):989–1002.
Du XJ, Wang JL, Iqbal S, Li HJ, Cao ZT, Wang YC, Du JZ, Wang J. The effect of surface charge on oral absorption of polymeric nanoparticles. Biomater Sci. 2018;6(3):642–50.
Ren T, Wang Q, Xu Y, Cong L, Gou J, Tao X, Zhang Y, He H, Yin T, Zhang H, Zhang Y, Tang X. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. J Control Release. 2018;269:423–38.
Wei K, Gong F, Wu J, Tang W, Liao F, Han Z, Pei Z, Lei H, Wang L, Shao M, Liu Z, Cheng L. Orally administered Silicon Hydrogen Nanomaterials as Target Therapy to treat Intestinal diseases. ACS Nano. 2023;17(21):21539–52.
Li Y, Ji W, Peng H, Zhao R, Zhang T, Lu Z, Yang J, Liu R, Zhang X. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery. Theranostics. 2021;11(9):4452–66.
Knoll P, Hörmann N, Nguyen Le NM, Wibel R, Gust R, Bernkop-Schnürch A. Charge converting nanostructured lipid carriers containing a cell-penetrating peptide for enhanced cellular uptake. J Colloid Interface Sci. 2022;628(Pt A):463–75.
Akbari A, Lavasanifar A, Wu J. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures. Acta Biomater. 2017;64:249–58.
Tan X, Yin N, Liu Z, Sun R, Gou J, Yin T, Zhang Y, He H, Tang X. Hydrophilic and Electroneutral nanoparticles to overcome mucus trapping and enhance oral delivery of insulin. Mol Pharm. 2020;17(9):3177–91.
Xu S, Yang Q, Wang R, Tian C, Ji Y, Tan H, Zhao P, Kaplan DL, Wang F, Xia Q. Genetically engineered pH-responsive silk sericin nanospheres with efficient therapeutic effect on ulcerative colitis. Acta Biomater. 2022;144:81–95.
Tada-Oikawa S, Eguchi M, Yasuda M, Izuoka K, Ikegami A, Vranic S, Boland S, Tran L, Ichihara G, Ichihara S. Functionalized surface-charged SiO2 nanoparticles induce pro-inflammatory responses, but are not Lethal to Caco-2 cells. Chem Res Toxicol. 2020;33(5):1226–36.
Wu J, Yi S, Cao Y, Zu M, Li B, Yang W, Shahbazi MA, Wan Y, Reis RL, Kundu SC, Shi X, Xiao B. Dual-driven nanomotors enable tumor penetration and hypoxia alleviation for calcium overload-photo-immunotherapy against colorectal cancer. Biomaterials. 2023;302:122332.
Wade J, Salerno F, Kilbride RC, Kim DK, Schmidt JA, Smith JA, LeBlanc LM, Wolpert EH, Adeleke AA, Johnson ER, Nelson J, Mori T, Jelfs KE, Heutz S, Fuchter MJ. Controlling anisotropic properties by manipulating the orientation of chiral small molecules. Nat Chem. 2022;14(12):1383–89.
Jiang H, Liu R, Wang L, Wang X, Zhang M, Lin S, Cao Z, Wu F, Liu Y, Liu J. Chiral-selective Antigen-Presentation by Supramolecular Chiral Polymer Micelles. Adv Mater. 2023;35(5):e2208157.
Chen X, Cheng Y, Pan Q, Wu L, Hao X, Bao Z, Li X, Yang M, Luo Q, Li H. Chiral Nanosilica Drug Delivery systems Stereoselectively interacted with the intestinal mucosa to improve the oral adsorption of insoluble drugs. ACS Nano. 2023;17(4):3705–22.
Wang Y, Zhao L, Dai Y, Xu M, Zhou R, Zhou B, Gou K, Zeng R, Xu L, Li H. Enantioselective oral absorption of Molecular Chiral Mesoporous silica nanoparticles. Adv Mater. 2023;35(49):e2307900.
Xin W, Wang L, Lin J, Wang Y, Pan Q, Han Y, Bao Z, Zong S, Cheng Y, Chen X, Zhao L, Li H. Mesoporous silica nanoparticles with chiral pattern topological structure function as antiskid tires on the intestinal mucosa to facilitate oral drugs delivery. Asian J Pharm Sci. 2023;18(2):100795.
